Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Diffuse”

318 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 318 results

Very early researchUnknownNCT05085444
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma

Who this might be right for
SclerodermaAutoimmune Diseases
Zhejiang University 9
Large-scale testing (Phase 3)Looking for participantsNCT06328777
What this trial is testing

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Diseases
Cabaletta Bio 37
Not applicableStudy completedNCT04179292
What this trial is testing

The Effect of Physiotherapy Program in Scleroderma Patients

Who this might be right for
SclerodermaSystemic SclerosisHand Rheumatism+2 more
Istanbul University 40
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05925803
What this trial is testing

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Who this might be right for
Systemic SclerosisScleroderma
AstraZeneca 314
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT01878526
What this trial is testing

Gastroesophageal Reflux Treatment in Scleroderma

Who this might be right for
Gastroesophageal Reflux DiseaseSystemic SclerosisScleroderma
Khon Kaen University 80
Testing effectiveness (Phase 2)Ended earlyNCT03919799
What this trial is testing

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
System; SclerosisDiffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 36
Testing effectiveness (Phase 2)WithdrawnNCT02588625
What this trial is testing

A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Scleroderma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT03844061
What this trial is testing

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 30
Large-scale testing (Phase 3)Study completedNCT02896205
What this trial is testing

Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 41
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Early research (Phase 1)WithdrawnNCT02680717
What this trial is testing

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

Who this might be right for
Scleroderma
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT03041025
What this trial is testing

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
GlaxoSmithKline 35
Not applicableEnded earlyNCT05181644
What this trial is testing

Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.

Who this might be right for
UlcerAcral NevusScleroderma+1 more
Emoled 36
Large-scale testing (Phase 3)Study completedNCT01862926
What this trial is testing

Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Inflammatory Myositis+1 more
Royal Brompton & Harefield NHS Foundation Trust 104
Testing effectiveness (Phase 2)Looking for participantsNCT03211793
What this trial is testing

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

Who this might be right for
Systemic SclerosisDigital Ulcer
UMC Utrecht 20
Not applicableStudy completedNCT06772896
What this trial is testing

Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis

Who this might be right for
SclerodermaSystemic Sclerosis (SSc)Scleroderma (Limited and Diffuse)
Lady Davis Institute 851
Testing effectiveness (Phase 2)Study completedNCT00005675
What this trial is testing

Oral Type I Collagen for Relieving Scleroderma

Who this might be right for
SclerodermaConnective Tissue Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 168
Not applicableStudy completedNCT02339441
What this trial is testing

Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Early Diffuse Cutaneous Systemic Sclerosis
University of Manchester 320
Next Page